These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 2954014)
1. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014 [TBL] [Abstract][Full Text] [Related]
2. Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis. Wolf GT; Schmaltz S; Hudson J; Robson H; Stackhouse T; Peterson KA; Poore JA; McClatchey KD Arch Otolaryngol Head Neck Surg; 1987 Nov; 113(11):1200-6. PubMed ID: 3499156 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488 [TBL] [Abstract][Full Text] [Related]
4. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report. Rabin BS; Johnson J; Claassen D Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437 [TBL] [Abstract][Full Text] [Related]
5. Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma. Wolf GT; Lovett EJ; Peterson KA; Beauchamp ML; Baker SR Arch Otolaryngol; 1984 Nov; 110(11):731-5. PubMed ID: 6237633 [TBL] [Abstract][Full Text] [Related]
6. Lymphocyte phenotypes at tumor margins in patients with head and neck cancer. Guo M; Rabin BS; Johnson JT; Paradis IL Head Neck Surg; 1987; 9(5):265-71. PubMed ID: 2957343 [TBL] [Abstract][Full Text] [Related]
7. Definite vs adjuvant radiotherapy. Comparative effects on lymphocyte subpopulations in patients with head and neck squamous carcinoma. Wolf GT; Amendola BE; Diaz R; Lovett EJ; Hammerschmidt RM; Peterson KA Arch Otolaryngol; 1985 Nov; 111(11):716-26. PubMed ID: 2932094 [TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphoreticular cells. Histologic and immunohistologic investigations performed on metastasizing squamous cell carcinomas of the head and neck. Horst HA; Horny HP Cancer; 1991 Dec; 68(11):2397-402. PubMed ID: 1933776 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of mononuclear cell infiltrates in squamous cell carcinoma of oral cavity and paranasal sinus. Ogawa Y; Maeda T; Seguchi H; Yoshida S; Inomata T; Hamada F; Kishimoto S; Saito H; Osaki T Oncology; 1987; 44(4):219-23. PubMed ID: 2956548 [TBL] [Abstract][Full Text] [Related]
10. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients. Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083 [TBL] [Abstract][Full Text] [Related]
11. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck. Bier J; Bitter K; Nicklisch U J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210 [TBL] [Abstract][Full Text] [Related]
12. T-cell subpopulations in head and neck carcinoma. Johnson JT; Rabin BS; Hirsch B; Thearle PB Otolaryngol Head Neck Surg; 1984 Aug; 92(4):381-5. PubMed ID: 6237299 [TBL] [Abstract][Full Text] [Related]
13. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT; Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675 [TBL] [Abstract][Full Text] [Related]
14. The relationship of circulating IgA to cellular immunity in head and neck cancer patients. Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661 [TBL] [Abstract][Full Text] [Related]
15. [Changes of peripheral lymphocyte subsets in patients with oral squamous carcinoma]. Moroyama T; Endo K; Hazutani J; Iwao I; Shiratsuki T; Mitsui K; Sugihara K; Okahara Y; Hara J; Sakamoto T Gan No Rinsho; 1985 Feb; 31(2):117-21. PubMed ID: 3157809 [TBL] [Abstract][Full Text] [Related]
16. Beta endorphin enhances in vitro lymphokine production in patients with squamous carcinoma of the head and neck. Wolf GT; Peterson KA Otolaryngol Head Neck Surg; 1986 Feb; 94(2):224-9. PubMed ID: 2938055 [TBL] [Abstract][Full Text] [Related]
17. Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2. Whiteside TL; Heo DS; Chen K; Adler A; Johnson JT; Herberman RB Prog Clin Biol Res; 1987; 244():213-22. PubMed ID: 3309998 [No Abstract] [Full Text] [Related]
19. Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck. Loose D; Signore A; Bonanno E; Vermeersch H; Dierckx R; Deron P; Van de Wiele C Cancer Biother Radiopharm; 2008 Feb; 23(1):25-33. PubMed ID: 18298326 [TBL] [Abstract][Full Text] [Related]
20. An immunological outcome predictive score for head and neck carcinoma patients. Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]